ID
5462
Description
CWS-2007-HR: A randomised phase-III trial of the Cooperative Soft-Tissue-Study-Group for localised high-risk rhabdomyosarcoma and localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in children, adolescents, and young adults http://clinicaltrials.gov/show/NCT00876031 http://www.cws.olgahospital-stuttgart.de
Link
http://clinicaltrials.gov/show/NCT00876031
Keywords
Versions (1)
- 8/6/14 8/6/14 - Martin Dugas
Uploaded on
August 6, 2014
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
CWS-2007-HR B3 - Primaere Standardtherapie DRKS00003774
B3 - Primaere Standardtherapie
- StudyEvent: SE
Description
Primäre Chemotherapie
Description
Protokoll der primären Chemotherapie
Data type
integer
Description
andere Therapieprotokolle
Data type
text
Description
Therapieschema
Data type
integer
Description
Bezeichnung abweichendes therapieschema
Data type
text
Description
Beginn der primären Chemotherapie
Data type
date
Description
Ende der primären Chemotherapie
Data type
date
Description
Primäre Radiotherapie
Description
Primäre Radiotherapie erhalten
Data type
integer
Description
Beginn der primären Radiotherape
Data type
date
Description
Radiotherapie-Ende
Data type
date
Description
Anzahl Fraktionierung
Data type
integer
Description
Bestralungs-Einzeldosis
Data type
float
Measurement units
- Gray
Description
Gesamtdosis
Data type
float
Measurement units
- Gray
Description
Sekundäre Resektion
Description
Sekundäre Resektion durchgeführt?
Data type
integer
Description
Datum der sekundären Resektion
Data type
date
Description
Art der sekundären Resektion
Data type
integer
Description
Betroffenes Organ derResektion
Data type
text
Description
Resektionsergebnis
Data type
integer
Description
Remissionsstatus
Similar models
B3 - Primaere Standardtherapie
- StudyEvent: SE
No comments